CytomX Therapeutics (CTMX) Non Operating Interest Expenses (2014 - 2017)
CytomX Therapeutics (CTMX) recorded Non Operating Interest Expenses of $206,000 in Q1 2017, down 41.6% from $353,000 a year earlier and down 47.0% from the prior quarter.
Powered by 
Analysis
CytomX Therapeutics (CTMX) Non Operating Interest Expenses (2014 - 2017) Analysis & Trends
On a TTM basis, CytomX Therapeutics' Non Operating Interest Expenses came in at $1.54 million as of Mar 31, 2017, down 16.9% year-over-year; for FY2016, it was $1.69 million, down 2.5% from FY2015.
- Annual Non Operating Interest Expenses has a three-year compound annual growth rate of 88.0% (FY2013 to FY2016).
- Across earlier years, Non Operating Interest Expenses came in at $1.73 million in FY2015 (+255.6%), $487,000 in FY2014 (+91.7%) and $254,000 in FY2013.
- The Q1 2017 figure is the lowest quarterly Non Operating Interest Expenses since Q4 2014.
- On a year-over-year basis, Non Operating Interest Expenses rose in five of the last seven quarters, with growth averaging 107.9%.
- Per Business Quant, the preceding three quarters came in at $389,000 (Q4 2016), $482,000 (Q3 2016) and $465,000 (Q2 2016).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | CytomX Therapeutics | 592.69 Mn | -364.98 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2017 | 206,000.00 |
| Dec 31, 2016 | 389,000.00 |
| Sep 30, 2016 | 482,000.00 |
| Jun 30, 2016 | 465,000.00 |
| Mar 31, 2016 | 353,000.00 |
| Dec 31, 2015 | 376,000.00 |
| Sep 30, 2015 | 718,000.00 |
| Jun 30, 2015 | 408,000.00 |
| Mar 31, 2015 | 230,000.00 |
| Dec 31, 2014 | 109,000.00 |
| Sep 30, 2014 | 117,000.00 |
API Access
CytomX Therapeutics Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=CTMX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "CTMX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=CTMX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();